trial · primary record
gecacitinib Hydrochloride Tablets
Myeloid Neoplasms With Myelofibrosis
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2029-09-30 |
| Primary endpoint | Engraftment Rate at Day +28 Post-Transplant |
| Registry ID | NCT07883382 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:38.973Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07883382
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.